Revvity reported $10.76B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Agilent USD 35.84B 3.23B Sep/2025
Align Technology USD 13.72B 2.09B Jun/2025
Bio Techne USD 8.07B 1.2B Jun/2025
Bio-Rad Laboratories USD 6.53B 284M Jun/2025
Bruker USD 6.24B 89M Jun/2025
Charles River Laboratories USD 7.37B 25M Jun/2025
Cspc Pharmaceutical HKD 57.03B 1.39B Mar/2025
Danaher USD 142.28B 4.39B Jun/2025
Dentsply International USD 3.16B 188M Jun/2025
Dianthus Therapeutics USD 692M 93M Sep/2025
Divis Laboratories Ltd 1.81T 277.71B Jun/2025
Edwards Lifesciences USD 45.88B 3.27B Jun/2025
Exact Sciences USD 10.02B 1.86B Jun/2025
Hologic USD 14.52B 659M Jun/2025
Illumina USD 15.1B 2.54B Jun/2025
Intuitive Surgical USD 194.77B 17.33B Jun/2025
IQVIA Holdings USD 27.26B 3.82B Jun/2025
Kangmei Pharma CNY 26.2B 2.77B Jun/2025
Knight Therapeutics CAD 599.03M 24.75M Sep/2024
Laboratorios Farma EUR 3.06B 257.39M Sep/2025
Laboratory Of America USD 21.97B 2.5B Jun/2025
Mettler Toledo International USD 24.41B 201M Jun/2025
Neuren Pharmaceuticals AUD 1.6B 1.12B Dec/2024
Organigram Holdings CAD 222.95M 23.4M Sep/2025
Pharma Mar EUR 1.39B 91.01M Jun/2025
Qiagen NV EUR 10.41B 2.39B Jun/2025
Quest Diagnostics USD 20.05B 1.17B Jun/2025
Quidel USD 1.95B 407M Jun/2025
Repligen USD 6.99B 160M Jun/2025
Revvity USD 11.53B 1.18B Jun/2025
Sartorius EUR 13.56B 794.37M Jun/2025
Thermo Fisher Scientific USD 154.12B 33.72B Jun/2025
Tilray CAD 647.69M 211.12M Aug/2025
Waters USD 20.97B 956M Jun/2025
Zz Pientze Pharmaceu 120.67B 1.25B Jun/2025